Keystone Symposium

June 18th, 2019 – Keystone, CO, USA

Dieter Willbold will present PRI-002 at the Keystone Symposium “Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2) in Keystone, CO, USA.

News & Events:

Dr. Dagmar Juergens will attend the annual AAIC online conference

22. June 2021

Funding from The Michael J. Fox Foundation

24. February 2021

Priavoid closes financing round

12. February 2021

Sprunginnovationsprojekt geht neue Wege in der Alzheimer-Therapie

11. February 2021

Alzheimer´s Research: Important Milestone for PRI-002

4. February 2021

Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

9. December 2020

New CEO of Priavoid

2. September 2020

Priavoid Headquarters at LSC Düsseldorf

6. March 2020

Seed Investment

6. May 2019

Prof. Willbold´s interview with PharmaVentures

23. January 2018

Clinical trial with PRI-002

31. May 2017